Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Dec;63(6):1578–1587. doi: 10.1086/302172

Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy.

J A Engelman 1, X Zhang 1, F Galbiati 1, D Volonte 1, F Sotgia 1, R G Pestell 1, C Minetti 1, P E Scherer 1, T Okamoto 1, M P Lisanti 1
PMCID: PMC1377628  PMID: 9837809

Full Text

The Full Text of this article is available as a PDF (258.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M. P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 1997 Mar 7;272(10):6525–6533. doi: 10.1074/jbc.272.10.6525. [DOI] [PubMed] [Google Scholar]
  2. Couet J., Sargiacomo M., Lisanti M. P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem. 1997 Nov 28;272(48):30429–30438. doi: 10.1074/jbc.272.48.30429. [DOI] [PubMed] [Google Scholar]
  3. Engelman J. A., Chu C., Lin A., Jo H., Ikezu T., Okamoto T., Kohtz D. S., Lisanti M. P. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 1998 May 29;428(3):205–211. doi: 10.1016/s0014-5793(98)00470-0. [DOI] [PubMed] [Google Scholar]
  4. Engelman J. A., Lee R. J., Karnezis A., Bearss D. J., Webster M., Siegel P., Muller W. J., Windle J. J., Pestell R. G., Lisanti M. P. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem. 1998 Aug 7;273(32):20448–20455. doi: 10.1074/jbc.273.32.20448. [DOI] [PubMed] [Google Scholar]
  5. Engelman J. A., Wykoff C. C., Yasuhara S., Song K. S., Okamoto T., Lisanti M. P. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem. 1997 Jun 27;272(26):16374–16381. doi: 10.1074/jbc.272.26.16374. [DOI] [PubMed] [Google Scholar]
  6. Engelman J. A., Zhang X. L., Galbiati F., Lisanti M. P. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett. 1998 Jun 16;429(3):330–336. doi: 10.1016/s0014-5793(98)00619-x. [DOI] [PubMed] [Google Scholar]
  7. Engelman J. A., Zhang X. L., Lisanti M. P. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett. 1998 Oct 9;436(3):403–410. doi: 10.1016/s0014-5793(98)01134-x. [DOI] [PubMed] [Google Scholar]
  8. Faux M. C., Scott J. D. Molecular glue: kinase anchoring and scaffold proteins. Cell. 1996 Apr 5;85(1):9–12. doi: 10.1016/s0092-8674(00)81075-2. [DOI] [PubMed] [Google Scholar]
  9. Galbiati F., Volonte D., Engelman J. A., Watanabe G., Burk R., Pestell R. G., Lisanti M. P. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 1998 Nov 16;17(22):6633–6648. doi: 10.1093/emboj/17.22.6633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Galbiati F., Volonte D., Gil O., Zanazzi G., Salzer J. L., Sargiacomo M., Scherer P. E., Engelman J. A., Schlegel A., Parenti M. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10257–10262. doi: 10.1073/pnas.95.17.10257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. García-Cardeña G., Martasek P., Masters B. S., Skidd P. M., Couet J., Li S., Lisanti M. P., Sessa W. C. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem. 1997 Oct 10;272(41):25437–25440. doi: 10.1074/jbc.272.41.25437. [DOI] [PubMed] [Google Scholar]
  12. Giordano S., Ponzetto C., Di Renzo M. F., Cooper C. S., Comoglio P. M. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature. 1989 May 11;339(6220):155–156. doi: 10.1038/339155a0. [DOI] [PubMed] [Google Scholar]
  13. Glenney J. R., Jr The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett. 1992 Dec 7;314(1):45–48. doi: 10.1016/0014-5793(92)81458-x. [DOI] [PubMed] [Google Scholar]
  14. Ikezu T., Trapp B. D., Song K. S., Schlegel A., Lisanti M. P., Okamoto T. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J Biol Chem. 1998 Apr 24;273(17):10485–10495. doi: 10.1074/jbc.273.17.10485. [DOI] [PubMed] [Google Scholar]
  15. Ikezu T., Ueda H., Trapp B. D., Nishiyama K., Sha J. F., Volonte D., Galbiati F., Byrd A. L., Bassell G., Serizawa H. Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Res. 1998 Sep 7;804(2):177–192. doi: 10.1016/s0006-8993(98)00498-3. [DOI] [PubMed] [Google Scholar]
  16. Koleske A. J., Baltimore D., Lisanti M. P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1381–1385. doi: 10.1073/pnas.92.5.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lee S. J., Liyanage U., Bickel P. E., Xia W., Lansbury P. T., Jr, Kosik K. S. A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med. 1998 Jun;4(6):730–734. doi: 10.1038/nm0698-730. [DOI] [PubMed] [Google Scholar]
  18. Lee S. W., Reimer C. L., Oh P., Campbell D. B., Schnitzer J. E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene. 1998 Mar;16(11):1391–1397. doi: 10.1038/sj.onc.1201661. [DOI] [PubMed] [Google Scholar]
  19. Li S., Couet J., Lisanti M. P. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem. 1996 Nov 15;271(46):29182–29190. doi: 10.1074/jbc.271.46.29182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Li S., Galbiati F., Volonte D., Sargiacomo M., Engelman J. A., Das K., Scherer P. E., Lisanti M. P. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett. 1998 Aug 28;434(1-2):127–134. doi: 10.1016/s0014-5793(98)00945-4. [DOI] [PubMed] [Google Scholar]
  21. Li S., Song K. S., Koh S. S., Kikuchi A., Lisanti M. P. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis. J Biol Chem. 1996 Nov 8;271(45):28647–28654. doi: 10.1074/jbc.271.45.28647. [DOI] [PubMed] [Google Scholar]
  22. Lisanti M. P., Scherer P. E., Tang Z., Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 1994 Jul;4(7):231–235. doi: 10.1016/0962-8924(94)90114-7. [DOI] [PubMed] [Google Scholar]
  23. Lisanti M. P., Scherer P. E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., Tu Y. H., Cook R. F., Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol. 1994 Jul;126(1):111–126. doi: 10.1083/jcb.126.1.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liu J., Oh P., Horner T., Rogers R. A., Schnitzer J. E. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem. 1997 Mar 14;272(11):7211–7222. doi: 10.1074/jbc.272.11.7211. [DOI] [PubMed] [Google Scholar]
  25. Liu P., Ying Y., Anderson R. G. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13666–13670. doi: 10.1073/pnas.94.25.13666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McNally E. M., de Sá Moreira E., Duggan D. J., Bönnemann C. G., Lisanti M. P., Lidov H. G., Vainzof M., Passos-Bueno M. R., Hoffman E. P., Zatz M. Caveolin-3 in muscular dystrophy. Hum Mol Genet. 1998 May;7(5):871–877. doi: 10.1093/hmg/7.5.871. [DOI] [PubMed] [Google Scholar]
  27. Minetti C., Sotgia F., Bruno C., Scartezzini P., Broda P., Bado M., Masetti E., Mazzocco M., Egeo A., Donati M. A. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998 Apr;18(4):365–368. doi: 10.1038/ng0498-365. [DOI] [PubMed] [Google Scholar]
  28. Oka N., Yamamoto M., Schwencke C., Kawabe J., Ebina T., Ohno S., Couet J., Lisanti M. P., Ishikawa Y. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem. 1997 Dec 26;272(52):33416–33421. doi: 10.1074/jbc.272.52.33416. [DOI] [PubMed] [Google Scholar]
  29. Okamoto T., Schlegel A., Scherer P. E., Lisanti M. P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 1998 Mar 6;273(10):5419–5422. doi: 10.1074/jbc.273.10.5419. [DOI] [PubMed] [Google Scholar]
  30. Parton R. G. Caveolae and caveolins. Curr Opin Cell Biol. 1996 Aug;8(4):542–548. doi: 10.1016/s0955-0674(96)80033-0. [DOI] [PubMed] [Google Scholar]
  31. Pisters L. L., Troncoso P., Zhau H. E., Li W., von Eschenbach A. C., Chung L. W. c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol. 1995 Jul;154(1):293–298. [PubMed] [Google Scholar]
  32. Rubin C. S. A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim Biophys Acta. 1994 Dec 30;1224(3):467–479. [PubMed] [Google Scholar]
  33. Sager R., Sheng S., Anisowicz A., Sotiropoulou G., Zou Z., Stenman G., Swisshelm K., Chen Z., Hendrix M. J., Pemberton P. RNA genetics of breast cancer: maspin as paradigm. Cold Spring Harb Symp Quant Biol. 1994;59:537–546. doi: 10.1101/sqb.1994.059.01.060. [DOI] [PubMed] [Google Scholar]
  34. Sargiacomo M., Scherer P. E., Tang Z., Kübler E., Song K. S., Sanders M. C., Lisanti M. P. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9407–9411. doi: 10.1073/pnas.92.20.9407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sargiacomo M., Sudol M., Tang Z., Lisanti M. P. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol. 1993 Aug;122(4):789–807. doi: 10.1083/jcb.122.4.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Scherer P. E., Lewis R. Y., Volonte D., Engelman J. A., Galbiati F., Couet J., Kohtz D. S., van Donselaar E., Peters P., Lisanti M. P. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem. 1997 Nov 14;272(46):29337–29346. doi: 10.1074/jbc.272.46.29337. [DOI] [PubMed] [Google Scholar]
  37. Scherer P. E., Lisanti M. P. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes. Dynamic regulation by extracellular glucose and intracellular metabolites. J Biol Chem. 1997 Aug 15;272(33):20698–20705. doi: 10.1074/jbc.272.33.20698. [DOI] [PubMed] [Google Scholar]
  38. Scherer P. E., Lisanti M. P., Baldini G., Sargiacomo M., Mastick C. C., Lodish H. F. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol. 1994 Dec;127(5):1233–1243. doi: 10.1083/jcb.127.5.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Scherer P. E., Okamoto T., Chun M., Nishimoto I., Lodish H. F., Lisanti M. P. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):131–135. doi: 10.1073/pnas.93.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6460–6464. doi: 10.1073/pnas.95.11.6460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Smart E. J., Ying Y. S., Mineo C., Anderson R. G. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10104–10108. doi: 10.1073/pnas.92.22.10104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Song K. S., Li Shengwen, Okamoto T., Quilliam L. A., Sargiacomo M., Lisanti M. P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem. 1996 Apr 19;271(16):9690–9697. doi: 10.1074/jbc.271.16.9690. [DOI] [PubMed] [Google Scholar]
  43. Song K. S., Scherer P. E., Tang Z., Okamoto T., Li S., Chafel M., Chu C., Kohtz D. S., Lisanti M. P. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem. 1996 Jun 21;271(25):15160–15165. doi: 10.1074/jbc.271.25.15160. [DOI] [PubMed] [Google Scholar]
  44. Tang Z., Okamoto T., Boontrakulpoontawee P., Katada T., Otsuka A. J., Lisanti M. P. Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans. Implications for the molecular evolution of mammalian caveolin genes. J Biol Chem. 1997 Jan 24;272(4):2437–2445. doi: 10.1074/jbc.272.4.2437. [DOI] [PubMed] [Google Scholar]
  45. Tang Z., Scherer P. E., Okamoto T., Song K., Chu C., Kohtz D. S., Nishimoto I., Lodish H. F., Lisanti M. P. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem. 1996 Jan 26;271(4):2255–2261. doi: 10.1074/jbc.271.4.2255. [DOI] [PubMed] [Google Scholar]
  46. Yamamoto M., Toya Y., Schwencke C., Lisanti M. P., Myers M. G., Jr, Ishikawa Y. Caveolin is an activator of insulin receptor signaling. J Biol Chem. 1998 Oct 9;273(41):26962–26968. doi: 10.1074/jbc.273.41.26962. [DOI] [PubMed] [Google Scholar]
  47. Yang C. P., Galbiati F., Volonte D., Horwitz S. B., Lisanti M. P. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett. 1998 Nov 20;439(3):368–372. doi: 10.1016/s0014-5793(98)01354-4. [DOI] [PubMed] [Google Scholar]
  48. Yang G., Truong L. D., Timme T. L., Ren C., Wheeler T. M., Park S. H., Nasu Y., Bangma C. H., Kattan M. W., Scardino P. T. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res. 1998 Aug;4(8):1873–1880. [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES